Pancragen

Description

Pancragen is a synthetic short peptide bioregulator studied for its potential role in pancreatic cellular function and metabolic signaling pathways. Laboratory research has explored Pancragen in relation to pancreatic tissue, cellular regulation, gene-expression activity, and mechanisms involved in glucose and metabolic processes. Researchers use Pancragen to investigate how short peptide sequences may influence cellular maintenance, regeneration, and age-related changes within pancreatic tissues. Its research applications make it of particular interest in studies involving pancreatic biology, metabolic regulation, and cellular resilience. This compound is intended exclusively for laboratory research and scientific use and is not approved for human or animal consumption, medical treatment, or diagnostic procedures.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.